List of Excipients in API dexlansoprazole
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dexlansoprazole
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | ALUMINUM OXIDE | |
TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | CARRAGEENAN | |
TWI PHARMACEUTICALS INC | DEXLANSOPRAZOLE | dexlansoprazole | 24979-703 | FD&C BLUE NO. 2 | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing dexlansoprazole
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 | CARRAGEENAN |
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 | ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B |
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 | FD&C BLUE NO. 2 |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for dexlansoprazole
Excipient focus: ALUMINUM OXIDE
dexlansoprazole drug variants containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
A-S Medication Solutions | dexlansoprazole | 50090-5944 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing ALUMINUM OXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
dexlansoprazole drug variants containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
ENDO USA Inc | dexlansoprazole | 49884-148 |
REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
dexlansoprazole drug variants containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
ENDO USA Inc | dexlansoprazole | 49884-148 |
REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
Excipient focus: CALCIUM HYDROXIDE
dexlansoprazole drug variants containing CALCIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
ENDO USA Inc | dexlansoprazole | 49884-148 |
REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing CALCIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
Excipient focus: CARRAGEENAN
dexlansoprazole drug variants containing CARRAGEENAN
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing CARRAGEENAN
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
A-S Medication Solutions | dexlansoprazole | 50090-6514 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
dexlansoprazole drug variants containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
A-S Medication Solutions | dexlansoprazole | 50090-6514 |
Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B
dexlansoprazole drug variants containing ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing ETHYLCELLULOSE AQUEOUS DISPERSION TYPE B
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
dexlansoprazole drug variants containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
A-S Medication Solutions | dexlansoprazole | 50090-6514 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 2
dexlansoprazole drug variants containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing FD&C BLUE NO. 2
Company | Ingredient | NDC |
---|---|---|
ENDO USA Inc | dexlansoprazole | 49884-148 |
REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
dexlansoprazole drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
A-S Medication Solutions | dexlansoprazole | 50090-6514 |
Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 5
dexlansoprazole drug variants containing FD&C YELLOW NO. 5
Company | Ingredient | NDC |
---|---|---|
ENDO USA Inc | dexlansoprazole | 49884-148 |
REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing FD&C YELLOW NO. 5
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
dexlansoprazole drug variants containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
ENDO USA Inc | dexlansoprazole | 49884-148 |
REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing FD&C YELLOW NO. 6
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
dexlansoprazole drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-5956 |
Physicians Total Care Inc | dexlansoprazole | 54868-5998 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
dexlansoprazole drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
A-S Medication Solutions | dexlansoprazole | 50090-5944 |
>Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONO AND DIPALMITOSTEARATE
dexlansoprazole drug variants containing GLYCERYL MONO AND DIPALMITOSTEARATE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing GLYCERYL MONO AND DIPALMITOSTEARATE
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
dexlansoprazole drug variants containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
A-S Medication Solutions | dexlansoprazole | 50090-6514 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
dexlansoprazole drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Company | Ingredient | NDC |
---|---|---|
Physicians Total Care Inc | dexlansoprazole | 54868-5998 |
Physicians Total Care Inc | dexlansoprazole | 54868-6152 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
dexlansoprazole drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-5944 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
dexlansoprazole drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
A-S Medication Solutions | dexlansoprazole | 50090-6514 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
dexlansoprazole drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
dexlansoprazole drug variants containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
ENDO USA Inc | dexlansoprazole | 49884-148 |
REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
Excipient focus: LAURYL SULFATE
dexlansoprazole drug variants containing LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
ENDO USA Inc | dexlansoprazole | 49884-148 |
REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
dexlansoprazole drug variants containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
A-S Medication Solutions | dexlansoprazole | 50090-5944 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM CARBONATE
dexlansoprazole drug variants containing MAGNESIUM CARBONATE
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing MAGNESIUM CARBONATE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
>Company | >Ingredient | >NDC |
Excipient focus: MANNITOL
dexlansoprazole drug variants containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
ENDO USA Inc | dexlansoprazole | 49884-148 |
REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing MANNITOL
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
dexlansoprazole drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
A-S Medication Solutions | dexlansoprazole | 50090-5944 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
dexlansoprazole drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
Physicians Total Care Inc | dexlansoprazole | 54868-5998 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
dexlansoprazole drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
Takeda Pharmaceuticals America Inc | dexlansoprazole | 64764-171 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
dexlansoprazole drug variants containing METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
dexlansoprazole drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
ENDO USA Inc | dexlansoprazole | 49884-148 |
REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
dexlansoprazole drug variants containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
A-S Medication Solutions | dexlansoprazole | 50090-6514 |
Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
dexlansoprazole drug variants containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
A-S Medication Solutions | dexlansoprazole | 50090-5944 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
dexlansoprazole drug variants containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing POLYSORBATE 80
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
dexlansoprazole drug variants containing POTASSIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing POTASSIUM CHLORIDE
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
A-S Medication Solutions | dexlansoprazole | 50090-6514 |
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
dexlansoprazole drug variants containing POTASSIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing POTASSIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
dexlansoprazole drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
dexlansoprazole drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
ENDO USA Inc | dexlansoprazole | 49884-148 |
REMEDYREPACK INC | dexlansoprazole | 70518-3693 |
Bryant Ranch Prepack | dexlansoprazole | 72162-2214 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
dexlansoprazole drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
A-S Medication Solutions | dexlansoprazole | 50090-5944 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
dexlansoprazole drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
A-S Medication Solutions | dexlansoprazole | 50090-6514 |
Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
dexlansoprazole drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
A-S Medication Solutions | dexlansoprazole | 50090-6514 |
Golden State Medical Supply Inc | dexlansoprazole | 51407-746 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
dexlansoprazole drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
ENDO USA Inc | dexlansoprazole | 49884-148 |
A-S Medication Solutions | dexlansoprazole | 50090-4374 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
A-S Medication Solutions | dexlansoprazole | 50090-5944 |
>Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
dexlansoprazole drug variants containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
dexlansoprazole drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
dexlansoprazole drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
dexlansoprazole drug variants containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | dexlansoprazole | 0378-2085 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-001 |
TWI PHARMACEUTICALS INC | dexlansoprazole | 24979-703 |
>Company | >Ingredient | >NDC |
dexlansoprazole drug variants not containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.